The event will focus on revenue stream diversification, providing independent pharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.

Although there is no cure for MS, treatment focuses on recovery from attacks, reducing relapse, slowing disease progression, and managing multiple sclerosis symptoms.

In a session at PQA 2025, presenters discussed the impact of SDoH on health outcomes and how pharmacy teams can identify and address barriers.

In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.

The results place emphasis on female parents with low socioeconomic status for both declines in mental and physical health.

Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.

The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.

Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed her ongoing research regarding the potential impact of pharmaceutical tariffs on the prescription drug market.

Razanne Oueini, PharmD, MSc, CPHQ, discusses how rates of persistence to basal insulin were impacted after the IRA monthly cap.

The new approval is for a first-in-class TRPM8 receptor agonist to stimulate corneal sensory nerves to increase natural tear production.

The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.

Currently under development, the manufacturer’s investigational pandemic influenza vaccine is designed to target the H5 avian influenza virus, or bird flu.

The use of the terminology can alter the meaning when assigned to patients’ behaviors, unintentionally implying that barriers such as poverty or systemic racism are due to poor behavior or efforts.

The data show a decrease in all-cause mortality for sustained midlife weight loss achieved without surgical or pharmacological interventions.

Michael Hegener, PharmD, BCACP, discusses how workforce development can best address the evolving knowledge, skills, and abilities needed in community pharmacy practice.

Researchers evaluated PBM reimbursement practices in Medicare and whether they resulted in out-of-pocket cost increases for Part D beneficiaries.

Micah Cost, PharmD, MS, CAE, discusses the biggest issues currently impacting the pharmacy profession.

Kaitlin Bates, PharmD, discusses the results of implementing a program used to support standardized pharmacy quality measures.

Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.

This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.

Pharmacists play a critical role in vaccination and education for patients about the evolving infectious disease landscape.

Researchers aimed to estimate the impact of using behavioral science principles within communication intended for hypertension medication adherence.

Ustekinumab is a medication used to treat and manage inflammatory conditions, including psoriasis, psoriatic arthritis, and inflammatory bowel disease.

Michael Hegener, PharmD, BCACP, discusses what workflow changes are essential to support the expansion of patient care services in community pharmacies.

Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.